Latest news
Replimune's melanoma drug gets FDA nod but faces legal probe over data practices - PluangPluang · Fri, 07 Aug 2026 16:27:01 GMTReplimune's stock jumps after FDA approves its first skin cancer drug Tudriqev - PluangPluang · Fri, 07 Aug 2026 15:51:23 GMTClass action lawsuit filed against Replimune ov... - PluangPluang · Fri, 07 Aug 2026 15:51:11 GMT